Elon Musk's Neuralink explores deal with brain-computer firm that implanted chip into ALS patient

Elon Musk is reportedly looking at a potential investment deal between Neuralink and brain-computer startup Synchron that successfully implanted a chip into a severely paralyzed ALS patient in July. Four people who work or have worked at Neuralink told Reuters that Musk has expressed disappointment at the slow pace of progress on the company's brain implant device and recently approached the CEO of Synchron about a possible deal. Brooklyn-based Synchron made history when it implanted a 1.5-inch long brain-computer interface (BCI) called a Stentrode into a patient's brain without the need for cutting into their skull - by accessing the brain via blood vessels. In contrast, Neuralink's device, which is being tested on monkeys, requires surgery to make a small incision to implant it. Four people who work or have worked at Neuralink told Reuters that Musk has expressed disappointment at the slow pace of progress on the company's brain implant device, called the Link (seen above) Neuralink's device, which is being tested on monkeys, requires surgery to make a small incision to implant it, but Synchron's device does not require surgery.